FDA Watch
D. Kyle Sampson, J.D.
March 7, 2011
State sunshine laws in a post-federal sunshine law world
Read More »
Colleen Heisey, J.D.
October 8, 2010
CMC postapproval manufacturing changes reportable in annual reports
Read More »
Colleen Heisey, J.D.
September 1, 2010
Advertising and promotional activities by drug and device manufacturers are a significant and vigilant focus of the U.S. Food and Drug Administration's (FDA) enforcement activities. Of primary concern to FDA are the scope and manner in which risk inf…
Read More »
Gary C. Messplay, J.D. and Colleen Heisey
June 1, 2010
FDA enlists healthcare professionals in promotional surveillance
Read More »
Gary C. Messplay and Adele M. Kaplan Gilpin
April 5, 2010
FDA cautiously encourages use of adaptive design clinical trials
Read More »
Gary C. Messplay and Colleen Heisey
March 3, 2010
FDA's new guidance to aid sponsors with CSA
Read More »

